Literature DB >> 2749074

The control of confounding by intermediate variables.

J Robins1.   

Abstract

In epidemiologic studies of the effect of an exposure on disease, the crude association of exposure with disease may fail to reflect a causal association due to confounding by one or more covariates. Most previous discussions of confounding in the epidemiologic literature have considered only point exposure studies, that is, studies that measure exposure and covariate status only once, at start of follow-up. In this paper we offer definitions of confounding suitable for longitudinal studies that obtain data on exposure, covariate, and vital status at several points in time. An important difference between longitudinal studies and point exposure studies is that, in longitudinal studies, a time-dependent covariate can be simultaneously a confounder and an intermediate variable on the causal pathway from exposure to disease. In this paper I propose an estimator, the extended standardized risk difference, that provides control for confounding by a covariate that is simultaneously a confounder and an intermediate variable.

Mesh:

Year:  1989        PMID: 2749074     DOI: 10.1002/sim.4780080608

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  45 in total

Review 1.  Equivalence of the mediation, confounding and suppression effect.

Authors:  D P MacKinnon; J L Krull; C M Lockwood
Journal:  Prev Sci       Date:  2000-12

Review 2.  Adaptive treatment strategies in chronic disease.

Authors:  Philip W Lavori; Ree Dawson
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

3.  Marginal structural models for sufficient cause interactions.

Authors:  Tyler J Vanderweele; Stijn Vansteelandt; James M Robins
Journal:  Am J Epidemiol       Date:  2010-01-11       Impact factor: 4.897

4.  On quantifying the magnitude of confounding.

Authors:  Holly Janes; Francesca Dominici; Scott Zeger
Journal:  Biostatistics       Date:  2010-03-04       Impact factor: 5.899

5.  Quantifying Cancer Risk from Radiation.

Authors:  Alexander P Keil; David B Richardson
Journal:  Risk Anal       Date:  2017-12-06       Impact factor: 4.000

6.  Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor.

Authors:  Li Liu; Reiko Nishihara; Zhi Rong Qian; Fred K Tabung; Daniel Nevo; Xuehong Zhang; Mingyang Song; Yin Cao; Kosuke Mima; Yohei Masugi; Yan Shi; Annacarolina da Silva; Tyler Twombly; Mancang Gu; Wanwan Li; Tsuyoshi Hamada; Keisuke Kosumi; Kentaro Inamura; Jonathan A Nowak; David A Drew; Paul Lochhead; Katsuhiko Nosho; Kana Wu; Molin Wang; Wendy S Garrett; Andrew T Chan; Charles S Fuchs; Edward L Giovannucci; Shuji Ogino
Journal:  Gastroenterology       Date:  2017-09-01       Impact factor: 22.682

7.  Depressive Symptoms at HIV Testing and Two-Year All-Cause Mortality Among Men Who Inject Drugs in Vietnam.

Authors:  Sara N Levintow; Brian W Pence; Tran Viet Ha; Nguyen Le Minh; Teerada Sripaipan; Carl A Latkin; Pham The Vu; Vu Minh Quan; Constantine Frangakis; Vivian F Go
Journal:  AIDS Behav       Date:  2019-03

8.  Estimating the average treatment effect on survival based on observational data and using partly conditional modeling.

Authors:  Qi Gong; Douglas E Schaubel
Journal:  Biometrics       Date:  2016-05-18       Impact factor: 2.571

9.  Physical activity and lung cancer among non-smokers: a pilot molecular epidemiological study within EPIC.

Authors:  Andrew Rundle; John Richie; Karen Steindorf; Marco Peluso; Kim Overvad; Ole Raaschou-Nielsen; Francoise Clavel-Chapelon; Jacob P Linseisen; Heiner Boeing; Antonia Trichopoulou; Domenico Palli; Vittorio Krogh; Rosario Tumino; Salvatore Panico; Hendrik B Bueno-De-Mesquita; Petra H Peeters; Eiliv Lund; Carlos A Gonzalez; Carmen Martinez; Miren Dorronsoro; Aurelio Barricarte; M Jose Tormo; Josèr Quiros; Antonio Agudo; Goran Berglund; Bengt Jarvholm; Sheila Bingham; Timothy J Key; Emmanuelle Gormally; Rodolfo Saracci; Rudolf Kaaks; Elio Riboli; Paolo Vineis
Journal:  Biomarkers       Date:  2010-02       Impact factor: 2.658

10.  An EGFR and AKT Signaling Pathway was Identified with Mediation Model in Osteosarcomas Clinical Study.

Authors:  Huiyun Wu; Nicole E Muscato; Adriana Gonzalez; Yu Shyr
Journal:  Biomark Insights       Date:  2007-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.